|
rs11057864
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
|
rs1108131
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
|
rs2647012
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.
|
24925725 |
2014 |
|
rs6697139
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
|
rs7692514
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
|
rs7773456
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.
|
24925725 |
2014 |
|
rs958476
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
|
26980576 |
2016 |
|
rs1143679
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Conclusion CD11b rs1143679 appears to be associated with risk for SLE in the Han Chinese population, and may play an important role in the development of lupus nephritis.
|
29207897 |
2018 |
|
rs1143679
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Our meta-analyses confirm that the ITGAM rs1143679 polymorphism is associated with SLE susceptibility in different ethnic groups and demonstrate that the polymorphism is associated with LN in European.
|
25315704 |
2015 |
|
rs2910164
|
|
|
0.020 |
GeneticVariation |
BEFREE |
This is the first report documenting that the <i>miR-146a</i> rs2910164G/C and <i>miR-499</i> rs3746444 polymorphisms are associated with SLE susceptibility but not with LN.
|
29190882 |
2017 |
|
rs2910164
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The objective of this study was to identify the association between genotypes of miR-146a rs2910164 and expression of TRAF6 as well as the risk of lupus nephritis (LN).
|
29754557 |
2017 |
|
rs352140
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Both rs352139 (p=0.040, OR: 0.713, 95%CI: 0.516-0.985) and rs352140 (p=0.048, OR: 0.723, 95%CI: 0.525-0.997) were associated with LN in dominant model.
|
20497632 |
2010 |
|
rs352140
|
|
|
0.020 |
GeneticVariation |
BEFREE |
A significant genotypic and allelic association was revealed between TLR-9-rs352140 and both SLE and LN (P < 0·05).
|
28763101 |
2017 |
|
rs7708392
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Our results suggested that TNIP1 SNP (rs7708392) might be associated with the LN</span> in Egyptian SLE patients.
|
29589214 |
2018 |
|
rs7708392
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Comparing cases of systemic lupus erythematosus with nephritis and cases of systemic lupus erythematosus without nephritis revealed strong associations with lupus nephritis at rs7708392 in European Americans and rs4958881 in African Americans.
|
23970121 |
2013 |
|
rs10127939
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The low-binding haplotypes formed by 66L/R/H and 176F confer enhanced risk of lupus nephritis in African Americans.
|
24782186 |
2014 |
|
rs1061170
|
|
|
0.010 |
GeneticVariation |
BEFREE |
There was a significantly higher ratio of CC/CT genotypes of rs1061170 in lupus nephritis patients with class III than in the other two classes (class III vs. class IV vs. class V: 21.0% vs. 9.7% vs. 9.4%; P = .044).
|
28403670 |
2017 |
|
rs11203368
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Carriage of minor alleles of five other SNPs (rs11203366, rs11203367, rs874881, rs2240340, and rs11203368) was associated with increased occurrence of LN and hypertension.
|
30269634 |
2019 |
|
rs114580964
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We discovered five independent risk variants for LN within the MHC region, including <i>HLA-DRβ1</i> amino acid 11 (<i>P</i><sub>omnibus</sub><0.001), <i>HLA-DQβ1</i> amino acid 45 (<i>P</i><0.001; odds ratio, 0.58; 95% confidence interval, 0.52 to 0.65), <i>HLA-A</i> amino acid 156 (<i>P</i><sub>omnibus</sub><0.001), <i>HLA-DPβ1</i> amino acid 76 (<i>P</i><sub>omnibus</sub><0.001), and a missense variant in <i>PRRC2A</i> (rs114580964; <i>P</i><0.001; odds ratio, 0.38; 95% confidence interval, 0.30 to 0.49) at genome-wide significance.
|
28754791 |
2017 |
|
rs117026326
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Patients carrying genotype TT of rs117026326 had lower 24-hour urinary total protein (24 hours UTP, g/24 hours), 24-hour urinary protein level (g/L·24 hours), lower frequency of the proteinuria and lupus nephritis (LN).
|
31374066 |
2019 |
|
rs11889341
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In the case-control analysis of cohort I, four highly linked SNPs in STAT4 were associated with lupus nephritis with genome wide significance with p = 3.7 × 10(-9), OR 2.20 for the best SNP rs11889341.
|
24386384 |
2013 |
|
rs11893826
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A total of 111 patients with SLE (50 with SLE without nephritis, 55 with LN and 6 with simple urinary sediment abnormalities) and 62 healthy controls (HC) were genotyped for NCX1 rs11893826 (NCX1a) and rs434082 (NCX1b) and ADD2 rs4984 SNPs.
|
26045217 |
2015 |
|
rs11981433
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We found no association of PON2 SNPs with SLE risk but modest associations were observed with lupus nephritis (rs11981433, rs17876205, rs17876183) and immunologic disorder (rs11981433) in SLE patients (P = 0.013 to 0.042).
|
21223581 |
2011 |
|
rs1267969615
|
|
|
0.010 |
GeneticVariation |
BEFREE |
There was no association between genetic polymorphism of ACE, AGT M235T and AGTR1 A1166C and susceptibility to lupus nephritis, nor histological activity and chronicity indices in renal biopsy among the patients studied.
|
16047641 |
2005 |
|
rs1391441
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Four trans-eSNPs were observed to be associated with susceptibility to LN (P < 0.05), including ANKRD50 rs17008504, AGA rs2271100, PAK7 rs6056923, and TET2 rs1391441, while seven other trans-eSNPs showed marginal significant associations (0.05 < P < 0.1).
|
26509176 |
2015 |